Squamous Carcinoma Unknown Status Phase 2 Trials for Docetaxel (DB01248)

Also known as: Carcinoma, Squamous

IndicationStatusPhase
DBCOND0076732 (Squamous Carcinoma)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01497041A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line TreatmentTreatment